18 Oral - Recommendations from the European Commission Initiative on Breast Cancer on multigene tests to guide the use of adjuvant chemotherapy in patients who have hormone receptor positive, HER-2 negative, lymph node negative or up to 3 lymph nodes positive invasive breast cancer
| Autor: | Rossi, P.Giorgi 1, Lebeau, A. 2, Canelo-Aybar, C. 3, Rivera, M.C. Posso 3, Comas, D.Rigau 3, Quinn, C. 4, Coello, P.Alonso 3, McGarrigle, H. 5, Warman, S. 6, Broeders, M. 7, Duffy, S. 8, Langendam, M.W. 9, Gräwingholt, A. 10, Follmann, M. 11, Saz-Parkinson, Z. 12, Schünemann, H. 13 |
|---|---|
| Zdroj: | In European Journal of Cancer October 2020 138 Supplement 1:S12-S13 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect